Research ArticleBasic Science Investigation
PET of Tumor CXCR4 Expression with 4-18F-T140
Orit Jacobson, Ido D. Weiss, Dale O. Kiesewetter, Joshua M. Farber and Xiaoyuan Chen
Journal of Nuclear Medicine November 2010, 51 (11) 1796-1804; DOI: https://doi.org/10.2967/jnumed.110.079418
Orit Jacobson
Ido D. Weiss
Dale O. Kiesewetter
Joshua M. Farber
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 51, Issue 11
November 1, 2010
PET of Tumor CXCR4 Expression with 4-18F-T140
Orit Jacobson, Ido D. Weiss, Dale O. Kiesewetter, Joshua M. Farber, Xiaoyuan Chen
Journal of Nuclear Medicine Nov 2010, 51 (11) 1796-1804; DOI: 10.2967/jnumed.110.079418
Jump to section
Related Articles
Cited By...
- Modulators of CXCR4 and CXCR7/ACKR3 Function
- Single Dose of the CXCR4 Antagonist BL-8040 Induces Rapid Mobilization for the Collection of Human CD34+ Cells in Healthy Volunteers
- CXCR4 Ligands: The Next Big Hit?
- PET Imaging of Tenascin-C with a Radiolabeled Single-Stranded DNA Aptamer
- The High-Affinity CXCR4 Antagonist BKT140 Is Safe and Induces a Robust Mobilization of Human CD34+ Cells in Patients with Multiple Myeloma
- Interrogating Tumor Metabolism and Tumor Microenvironments Using Molecular Positron Emission Tomography Imaging. Theranostic Approaches to Improve Therapeutics
- PET of CXCR4 Expression by a 68Ga-Labeled Highly Specific Targeted Contrast Agent
- CXCR4-Based Imaging Agents
- Imaging CXCR4 Expression in Human Cancer Xenografts: Evaluation of Monocyclam 64Cu-AMD3465
- Prokineticin Receptor 1 Antagonist PC-10 as a Biomarker for Imaging Inflammatory Pain